Search research articles
Contact Us
Filters
Showing results (431-440 of 589) with videos related to
Page
of 59
Sort By:
Journal of Molecular Biology
|
June 27, 1997
Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation
F X Gomis-Rüth, M Gómez-Ortiz, J Vendrell, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Structure and function of lysosomal cysteine proteinases and their protein inhibitors
V Turk, J Brzin, B Lenarcic, et al.
The EMBO Journal
|
September 2, 1998
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
C Fernandez-Catalan, W Bode, R Huber, et al.
Angewandte Chemie (International Ed. in English)
|
February 29, 2024
Peptide-Directed Attachment of Hydroxylamines to Specific Lysines of IgG Antibodies for Bioconjugations with Acylboronates
Matthias Tanriver, Marco Müller, Mikail D Levasseur, et al.
The Journal of Biological Chemistry
|
June 20, 1998
Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity
J Chang, J Jin, P Lollar, et al.
The Journal of Biological Chemistry
|
June 24, 1994
Crystal structures, spectroscopic features, and catalytic properties of cobalt(II), copper(II), nickel(II), and mercury(II) derivatives of the zinc endopeptidase astacin. A correlation of structure and proteolytic activity
F X Gomis-Rüth, F Grams, I Yiallouros, et al.
Diabetes Care
|
July 12, 2014
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, et al.
The EMBO Journal
|
August 1, 1988
The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases
W Bode, R Engh, D Musil, et al.
Diabetes Care
|
July 17, 2015
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
Bruce W Bode, Janet B McGill, Daniel L Lorber, et al.
The Journal of Biological Chemistry
|
April 3, 1999
Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate
Q Meng, V Malinovskii, W Huang, et al.
Page
of 59
Search research articles
Search
Showing results (431-440 of 589) with videos related to
Sort By:
Page
of 59
Journal of Molecular Biology
|
June 27, 1997
Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation
F X Gomis-Rüth, M Gómez-Ortiz, J Vendrell, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Structure and function of lysosomal cysteine proteinases and their protein inhibitors
V Turk, J Brzin, B Lenarcic, et al.
The EMBO Journal
|
September 2, 1998
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor
C Fernandez-Catalan, W Bode, R Huber, et al.
Angewandte Chemie (International Ed. in English)
|
February 29, 2024
Peptide-Directed Attachment of Hydroxylamines to Specific Lysines of IgG Antibodies for Bioconjugations with Acylboronates
Matthias Tanriver, Marco Müller, Mikail D Levasseur, et al.
The Journal of Biological Chemistry
|
June 20, 1998
Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity
J Chang, J Jin, P Lollar, et al.
The Journal of Biological Chemistry
|
June 24, 1994
Crystal structures, spectroscopic features, and catalytic properties of cobalt(II), copper(II), nickel(II), and mercury(II) derivatives of the zinc endopeptidase astacin. A correlation of structure and proteolytic activity
F X Gomis-Rüth, F Grams, I Yiallouros, et al.
Diabetes Care
|
July 12, 2014
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, et al.
The EMBO Journal
|
August 1, 1988
The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases
W Bode, R Engh, D Musil, et al.
Diabetes Care
|
July 17, 2015
Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
Bruce W Bode, Janet B McGill, Daniel L Lorber, et al.
The Journal of Biological Chemistry
|
April 3, 1999
Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate
Q Meng, V Malinovskii, W Huang, et al.
Page
of 59